Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 5.28M P/E - EPS this Y 90.10% Ern Qtrly Grth -
Income -7.79M Forward P/E -1.20 EPS next Y 113.00% 50D Avg Chg -5.00%
Sales 5.18M PEG -0.05 EPS past 5Y - 200D Avg Chg -30.00%
Dividend N/A Price/Book 2.48 EPS next 5Y 40.00% 52W High Chg -73.00%
Recommedations 2.00 Quick Ratio 1.78 Shares Outstanding 8.48M 52W Low Chg 15.00%
Insider Own 9.65% ROA -49.09% Shares Float 4.38M Beta 0.30
Inst Own 37.96% ROE -1,035.44% Shares Shorted/Prior 36.64K/72.13K Price 1.58
Gross Margin 96.10% Profit Margin -150.41% Avg. Volume 26,391 Target Price -
Oper. Margin -112.65% Earnings Date May 13 Volume 8,683 Change 0.00%
About Evoke Pharma, Inc.

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Evoke Pharma, Inc. News
04/17/24 Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
03/21/24 Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
03/16/24 Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
03/15/24 Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
03/15/24 Q4 2023 Evoke Pharma Inc Earnings Call
03/14/24 Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
03/07/24 Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
02/14/24 Evoke Pharma Announces Closing of $7.5 Million Public Offering
02/09/24 Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
11/30/23 Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray
11/27/23 Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent
11/14/23 United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI
11/09/23 Evoke Pharma Reports Third Quarter 2023 Financial Results
10/31/23 Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023
10/23/23 7 Under-the-Radar Growth Stocks Ready to Make a Splash
10/18/23 Evoke Pharma’s Abstract Entitled “Superiority of Nasal Spray Compared to Orally Administered Metoclopramide in Reducing Healthcare Costs in Treating Diabetic Gastroparesis Patients” to Be Presented at The American College of Gastroenterology (ACG) 2023 Annual Meeting
09/14/23 Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI®
08/10/23 Evoke Pharma Reports Second Quarter 2023 Financial Results
08/07/23 Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) Meeting
07/25/23 Evoke Pharma and EVERSANA Announce Abstract Selection for Plenary Oral Presentation at The American College of Gastroenterology (ACG) 2023 Annual Meeting
EVOK Chatroom

User Image CPA1982 Posted - 3 days ago

$EVOK The worst thing about another reverse split is that the brokerage charges us 35 bucks per account to do the reverse split.

User Image CPA1982 Posted - 3 days ago

$EVOK I see that Evoke is going to host a Virtual Key Opinion Webinar on April 24th at 12 EST. And of course, Yale Jen will be the moderator. Why do they continue to have Yale Jen do anything? The man barely speaks english and asks nothing but dumb questions. If you're interested in the webinar, the registration information is in the April 17th press release in the Investor Relations section. GLA.

User Image FastFreddy69 Posted - 1 week ago

$EVOK

User Image devilinblue Posted - 1 week ago

$EVOK I JUST VOTED NO ON EVERYTHING ALL OF IT DO NOT CARE WHAT IT WAS..

User Image sks2345 Posted - 1 week ago

$EVOK proxy forms are out. Vote against everything

User Image Stock_Titan Posted - 1 week ago

$EVOK Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications https://www.stocktitan.net/news/EVOK/evoke-pharma-to-host-virtual-key-opinion-leader-kol-webinar-on-the-2ajvfno9bah8.html

User Image FastFreddy69 Posted - 1 week ago

$EVOK

User Image CPA1982 Posted - 1 week ago

$EVOK If, and or when, they file for bankruptcy will Eversana be treated as a secured creditor and get all the patent rights? If so, watch them all of a sudden sell the shit out of the drug and make tons. Just speculation on my part, but with the incompetence, and dare I say corruption, within this company anything is possible.

User Image CPA1982 Posted - 1 week ago

$EVOK The first quarter is over and they know the number of prescriptions filled. Why don't they release that number? I'm not asking for revenue, because insurance reimbursement can take time. They have to fill roughly 1,950 prescriptions per quarter to reach D'Onofrio's 14 million revenue forecast. Release it now so shareholders know if 14 million in revenue is possible or if you were blowing smoke up our ass to pump share price?

User Image tste9 Posted - 1 week ago

$EVOK Another joke coming up soon. ER lmao how stupid I was to of put $ into this POS

User Image FastFreddy69 Posted - 1 week ago

$EVOK

User Image CPA1982 Posted - 2 weeks ago

$EVOK Is anyone planning on adding shares to average down prior to the reverse split? Just curious.

User Image BeardownBulls77 Posted - 2 weeks ago

$EVOK voting no on every single capital raise until they show shareholders some real effort to sell the freaking drug! I rather a buyout at a lower share price of a few bucks than being reversed split into oblivion. It’s ridiculous and management keeps chasing the low hanging fruit rather than push an aggressive sales and marketing effort. I have yet to see ads, on social or in print media about Gimoti. If it’s as good as they say it is we should know it’s name like Ozempic and Rexulti.

User Image EFhutton420 Posted - 2 weeks ago

$EVOK let's get that RS show on the road! Would really love to re open a repetitive short play but need more shares available. Gotta love management keeps trying to stay afloat. Not for long!

User Image HypnoTrader Posted - 2 weeks ago

$EVOK 5 million without the warrants. At . 69 it quadruples

User Image EFhutton420 Posted - 2 weeks ago

$EVOK market cap at $5 million lol. Where I said it should be years ago. And now.....it's still over valued. Worth less than $1MM. Let's get that RS going so we can short again!

User Image devilinblue Posted - 3 weeks ago

$EVOK RAISE YOUR HAND… whose ass is buying and selling daily in this tight range? Me I’m just holding, but someone is trying to make Pennies while we wait. 📌 us here

User Image Tanny86 Posted - 3 weeks ago

$EVOK will be there be a R/S. I do not see any news around it and how this is related to Vanda Pharmaceuticals. Please enlighten me if you know it

User Image EFhutton420 Posted - 03/30/24

$EVOK told ya! Man it was fun shorting that management into oblivion. If they increase the share count we will re enter our short cycles. Evoke management can't beat us🤣

User Image CPA1982 Posted - 03/30/24

$EVOK Well I knew it was coming. Evoke is proposing another reverse stock split. They are also trying to increase the number of authorized shares to 100 million. It also looks like they are screwing us all over again with an amendment to warrants situation. Vote NO on every item in the upcoming annual proxy.

User Image yft212 Posted - 03/28/24

$EVOK Added.

User Image FastFreddy69 Posted - 03/28/24

$EVOK

User Image devilinblue Posted - 4 weeks ago

$EVOK EF HUTTON

User Image GaryGherkins Posted - 4 weeks ago

$EVOK one of my bigger misses, had a $200k gain only to sell for a loss, though did sell before the rs which equals $8+ current sp. thought gimoti would be another acthar gel, it wasn’t. another biotech lottery ticket that busted.

User Image devilinblue Posted - 1 month ago

@Burnshorts69 $TRVN $EVOK $VXRT $ZOM Luckily VXRT is back over $1 and moving daily

User Image EFhutton420 Posted - 1 month ago

$EVOK looks like the market cap finally went down to what we said it would get to several years ago

User Image EFhutton420 Posted - 1 month ago

$EVOK oops, management did it again

User Image tste9 Posted - 1 month ago

$EVOK It's gotta go up 10x for me to break even. I'm not worried.

User Image BeardownBulls77 Posted - 1 month ago

$EVOK we’ll see

User Image BeardownBulls77 Posted - 1 month ago

$EVOK anyone knows what Gonyer’s departure package include stock, warrant and options wise?